| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-040 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-047 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |
| 51285-050 | Ziac | bisoprolol fumarate and hydrochlorothiazide | Teva Women's Health, Inc. | NDA | Current |